发明名称 CD16A Binding Proteins and Use for the Treatment of Immune Disorders
摘要 CD 16A binding proteins useful for the reduction of a deleterious immune response asre described. In one aspect, humanized anti-cd16A antibodies, optionally lacking effector function, are used for the treatment of immune disorders such as idiopathic thrombocytopenic purpura and autoimme hemolytic anemia.
申请公布号 US2011152504(A1) 申请公布日期 2011.06.23
申请号 US20100904554 申请日期 2010.10.14
申请人 MACROGENICS, INC. 发明人 JOHNSON LESLIE S.;HUANG LING;LI HUA;TUAILLON NADINE
分类号 C07K16/28;C12N15/09;A61K39/395;A61P7/06;A61P29/00;A61P37/02;C07K16/46;C07K19/00;C12P21/08 主分类号 C07K16/28
代理机构 代理人
主权项
地址